| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.5M | +90.2% |
| SG&A Expense | $9.2M | +41.6% |
| Operating Income | -$13.7M | -54.5% |
| Interest Expense | $20K | -86.4% |
| Income Tax | $0 | — |
| Net Income | -$11.2M | +32.3% |
| EPS (Basic) | -$0.34 | +50.0% |
| EPS (Diluted) | -$0.34 | +50.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.0M | +52.6% |
| Current Assets | $14.2M | +54.4% |
| Total Assets | $16.4M | +39.1% |
| Current Liabilities | $12.7M | +38.6% |
| Total Liabilities | $13.7M | +29.7% |
| Stockholders' Equity | $2.7M | +118.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.9M | -85.9% |
| Capital Expenditures | $184K | -62.8% |
| Investing Cash Flow | -$184K | +62.8% |
| Financing Cash Flow | $16.9M | +22.6% |
| Free Cash Flow | -$12.1M | -75.2% |